← Back to Search

Project Dulce + Dulce Digital for Type 2 Diabetes

N/A
Recruiting
Led By Emily Rose N. San Diego, PhD
Research Sponsored by Scripps Whittier Diabetes Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with T2DM
Be older than 18 years old
Must not have
Not willing to carry a mobile phone
Severe illness precluding frequent visits to clinic
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a culturally adapted diabetes self-management program, delivered either in person or via text message, can improve diabetes knowledge and control in Filipino Americans with type 2 diabetes.

Who is the study for?
This trial is for Filipino-Americans with type 2 diabetes who can speak English and Tagalog, have an HbA1c level of ≥8%, and are registered or willing to register at a community clinic. It's not for those with severe illnesses, certain liver conditions, low body mass index, pregnancy, recent history of cancer (except some skin cancers), high creatinine levels, recent substance abuse issues, non-permanent residents in the area or current enrollees in Project Dulce.
What is being tested?
The study tests a culturally adapted diabetes self-management program called Project Dulce combined with a text messaging service named Dulce Digital. The goal is to improve diabetes knowledge and self-care among Filipino Americans by addressing cultural barriers. Effectiveness will be measured through changes in beliefs, attitudes towards diabetes management and hemoglobin A1C levels over 3 to 6 months.
What are the potential side effects?
Since this intervention involves education and digital communication rather than medication or invasive procedures, traditional side effects are not expected. However participants may experience discomfort from frequent monitoring of their health status.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with type 2 diabetes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not willing to carry a mobile phone.
Select...
I have a severe illness that prevents me from visiting the clinic often.
Select...
I have type 1 diabetes or had diabetes during pregnancy.
Select...
English or Tagalog is not my primary language.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline Diabetes Knowledge at 3 months
Change from Baseline Diabetes Knowledge at 6 months
Change from Baseline Health Belief Model Scale at 3 months
+3 more
Secondary study objectives
Change in Baseline Block Food Frequency Questionnaire at 3 months
Change in Baseline Block Food Frequency Questionnaire at 6 months
Change in Baseline Glycosylated Hemoglobin A1C (HbA1c) at 3 months; % Units
+5 more
Other study objectives
Participant Satisfaction
Recruitment and Retention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Project Dulce + Dulce DigitalExperimental Treatment1 Intervention
Patients will participate in a peer-led group diabetes self-management education and support program and receive ongoing support via text messages designed to improve knowledge, health beliefs, self-management behaviors and clinical outcomes.

Find a Location

Who is running the clinical trial?

Scripps Whittier Diabetes InstituteLead Sponsor
18 Previous Clinical Trials
5,401 Total Patients Enrolled
3 Trials studying Diabetes
1,422 Patients Enrolled for Diabetes
National Center for Advancing Translational Sciences (NCATS)NIH
371 Previous Clinical Trials
412,868 Total Patients Enrolled
Emily Rose N. San Diego, PhDPrincipal InvestigatorScripps Whittier Diabetes Institute

Media Library

Project Dulce + Dulce Digital Clinical Trial Eligibility Overview. Trial Name: NCT05378620 — N/A
Diabetes Research Study Groups: Project Dulce + Dulce Digital
Diabetes Clinical Trial 2023: Project Dulce + Dulce Digital Highlights & Side Effects. Trial Name: NCT05378620 — N/A
Project Dulce + Dulce Digital 2023 Treatment Timeline for Medical Study. Trial Name: NCT05378620 — N/A
~10 spots leftby Jun 2025